ClinicalIntelPulse
15 x402 APIs served from clinicalintelpulse.theaslangroupllc.com
Every listing from ClinicalIntelPulse that ToolVet tracks. Each one is called on a schedule without paying and scored out of 100.
At a glance
- Listings
- 15 x402 APIs
- Passing at the latest check
- 0 of 15
- Uptime, 30 days
- 0.0% on average across 15 listings
- Price
- $0.02 to $0.35 per call
- Trust score
- 13 to 17, median 13
- Paying wallets, 30 days
- 4 on its busiest listing
- Verified owner
- None
- Security findings
- None found
- Listed since
- 11 Oct 2026
The x402 Bazaar counts paying wallets per listing. A wallet that paid two listings counts twice. So the Bazaar saw between 4 and 18 different wallets paying ClinicalIntelPulse in 30 days.
All 15 listings
Ranked by trust score.
- 17trustClinical Trial CheckClinicalIntelPulse
ClinicalTrials.gov lookup, deterministic. Answers "what is the status of NCT02142738", "recruiting phase-3 melanoma trials", "Pfizer trial pipeline". Single trial by NCT id (status, phase, sponsor, enrollment, dates, countries) or search by condition/sponsor with phase and status filters. Typed records straight off the official v2 API — no LLM, no key, public domain.
$0.02per call on Base0.0% uptime, -, 4 paying agentsFailing, checked 3 h ago - 13trustClinical Trial BriefClinicalIntelPulse
Clinical trial deep dive by NCT ID — full trial design, primary/secondary endpoints, enrollment status and countries, sponsor, recruitment criteria, outcomes and publications for any ClinicalTrials.gov study. For research and biotech agents.
$0.1per call on Polygon0.0% uptime, -, 1 paying agentsFailing, checked 6 h ago - 13trustClinical Recall CheckClinicalIntelPulse
Is my medication recalled? Checks the FDA enforcement databases (drug AND food — infant formula and supplements are filed under food) for active and past recalls, explains the recall class (I/II/III) in plain language, and lays out what to do. For patient, caregiver, pharmacy, and health-assistant agents.
$0.1per call on Polygon0.0% uptime, -, 1 paying agentsFailing, checked 5 h ago - 13trustClinical Failure AnalysisClinicalIntelPulse
Clinical trial failure analysis for a disease area — why Phase 2/3 trials failed (wrong target, patient population, endpoint, dose, safety), failure taxonomy with percentages, phase-transition success rates and design lessons. Worldwide. For drug developers and biotech investors.
$0.2per call on Polygon0.0% uptime, -, 1 paying agentsFailing, checked 6 h ago - 13trustClinical Patient FinderClinicalIntelPulse
Recruiting clinical trial finder for a disease or diagnosis — actively recruiting trials with plain-language summaries, eligibility (who can/cannot join), country filter, contacts and how to apply, across 400,000+ ClinicalTrials.gov studies worldwide. For patient-advocacy and provider agents.
$0.1per call on Polygon0.0% uptime, -, 1 paying agentsFailing, checked 5 h ago - 13trustClinical Drug CheckClinicalIntelPulse
What is this medication? Plain-language explainer for any prescription or OTC drug from its FDA-approved label — what it treats, how to take it, boxed warnings, who should not take it, common and serious side effects, pregnancy notes. For patient, caregiver, pharmacy, and health-assistant agents.
$0.1per call on Polygon0.0% uptime, -, 1 paying agentsFailing, checked 5 h ago - 13trustClinical Deal SignalClinicalIntelPulse
Biotech M&A + licensing deal signal for clinical-stage drugs — Phase 2/3 assets most likely to be acquired or licensed, with acquisition targets, deal comps, transaction multiples and estimated deal values. Worldwide. For biotech-investing and BD agents.
$0.35per call on Polygon0.0% uptime, -, 1 paying agentsFailing, checked 5 h ago - 13trustClinical Deal Signal LiteClinicalIntelPulse
Deterministic preview of biotech M&A deal-signal candidates — Phase 2/3 trial counts and the industry-sponsored asset list straight off ClinicalTrials.gov, no LLM synthesis. For agents with small per-call budgets; upgrade to deal-signal for acquisition rationale, deal comps with dollar values, likely acquirers and timing signals.
$0.25per call on Polygon0.0% uptime, -, 1 paying agentsFailing, checked 5 h ago - 13trustClinical Global TrialsClinicalIntelPulse
Global clinical trial landscape for any disease — geographic distribution by country across WHO ICTRP registries (US, EU, China, India, Japan, Brazil, Africa and more), regulatory pathways, access gaps and unmet need by region. For CRO, global-pharma and advocacy agents.
$0.15per call on Polygon0.0% uptime, -, 1 paying agentsFailing, checked 5 h ago - 13trustClinical Mechanism MapClinicalIntelPulse
Drug mechanism-of-action + molecular target landscape for any disease — targets in active trials, approved agents by MOA, crowded vs novel mechanisms and first-in-class openings, with key publications. Worldwide. For drug-discovery and VC agents.
$0.2per call on Polygon0.0% uptime, -, 1 paying agentsFailing, checked 6 h ago - 13trustClinical Disease Landscape LiteClinicalIntelPulse
Deterministic preview of the disease pipeline landscape — Phase 2/3 trial counts, sponsor rollup, trial-status breakdown and a sample of trials straight off ClinicalTrials.gov. No LLM synthesis. For agents with small per-call budgets; upgrade to disease-landscape for approved drugs, mechanism gaps, PDUFA calendar, deal activity and an opportunity score.
$0.25per call on Polygon0.0% uptime, -, 1 paying agentsFailing, checked 5 h ago - 13trustClinical Disease LandscapeClinicalIntelPulse
Competitive drug pipeline landscape for any disease — full Phase 2/3 trial map, mechanism-of-action coverage, approved drugs, PDUFA calendar, M&A activity, opportunity gaps and investment thesis. Worldwide. For biotech and pharma intelligence agents.
$0.35per call on Polygon0.0% uptime, -, 1 paying agentsFailing, checked 5 h ago - 13trustClinical Sponsor IntelClinicalIntelPulse
Pharma/biotech company pipeline intelligence — full drug pipeline by phase, therapeutic-area coverage, FDA approval history, partnerships, competitive positioning and investment catalysts for any sponsor. Worldwide. For investor and M&A agents.
$0.2per call on Polygon0.0% uptime, -, 1 paying agentsFailing, checked 5 h ago - 13trustClinical Approval OutlookClinicalIntelPulse
FDA/EMA drug approval probability + PDUFA calendar for a disease area — which Phase 3 drugs are most likely to win approval in 12-24 months, with mechanism, trial results, approval-probability scores and historical phase-3 success rates. Worldwide. For biotech-investing and payer agents.
$0.25per call on Polygon0.0% uptime, -, 1 paying agentsFailing, checked 5 h ago - 13trustClinical Pipeline ScanClinicalIntelPulse
Clinical trial pipeline scan for any disease — all active Phase 2/3 trials with trial counts, sponsor landscape, geographic distribution, mechanism breakdown and pipeline density, across 400,000+ trials worldwide. For biotech-investing and pharma agents.
$0.15per call on Polygon0.0% uptime, -, 1 paying agentsFailing, checked 5 h ago
How these numbers are made
Each listing is called on a schedule without paying. Listings with usage or a verified owner are checked about every 30 minutes, others about every 6 hours. Uptime is the share of passing checks over 30 days, averaged across this provider's listings. Trust scores follow the published method. The figures on this page can be a few minutes behind the latest checks, and listings hidden after review aren't counted.